Pfizer’s twice-daily weight loss pill joins a long list of obesity drug flops
Before successful weight loss treatments such as Wegovy and Ozempic, the pharmaceutical path to treating obesity was strewn with failures dating back decades.
Similar Posts
US VP Harris calls for restraint as Israel strikes southern Gaza
Post Content Post Views: 60
Agilent Technologies Q3 2023 Earnings Preview
Post Content Post Views: 76
China consumption shows ‘no sign’ of a strong V-shaped recovery, McKinsey says
China’s consumer isn’t going to be spending big anytime soon, which means companies need to be more strategic to tap the massive market, according to McKinsey. Post Views: 52
German export sentiment improves in November – Ifo
Post Content Post Views: 50
Wells Fargo employees push for unionization amid labor disputes
Post Content Post Views: 54